Neupro (rotigotine transdermal system, from UCB and Schwarz Pharma) patches are being recalled due to the formation of rotigotine crystals in the patches. When the drug crystallizes, less drug is ...
UCB will need to resolve issues concerning crystal formation before regulators in the USA approve the Belgian firm’s Neupro patch for Parkinson’s disease and restless legs syndrome. UCB will need to ...
The World's Only Transdermal Dopamin Agonist, Neupro® Patch, Approved in Japan for Both Parkinson's Disease and Restless Legs Syndrome The only transdermal dopamine agonist*1 system, which helps ...
BRUSSELS, June 18 /PRNewswire-FirstCall/ --The first data to show that Neupro® (rotigotine transdermal system) significantly improved wellbeing and daily activities ...
Mc|K Healthcare said it resigned its largest account, UCB’s Neupro patch, as the agency shifts its creative vision. Last year Neupro (rotigotine), a patch for Parkinson’s disease and restless legs ...
Mc|K Healthcare said it resigned its largest account, UCB’s Neupro patch, as the agency overhauls its creative vision. Last year Neupro (rotigotine), a patch for Parkinson’s disease and restless legs ...
BRUSSELS, July 28 UCB today announced the results of a 6-month, randomized, double-blind, placebo-controlled clinical study, published in the journal Movement Disorders, showing that Neupro® ...
James Papadakis was two years into his battle with Parkinson's disease and his symptoms had taken a turn for the worse when his Baylor College of Medicine doctor suggested an experimental new skin ...
Latest safety and efficacy results for rotigotine in the treatment of moderate to severe restless legs syndrome presented at major North American neurology congress Brussels (Belgium), 13 April 2010, ...
Otsuka Pharmaceutical Co has developed the Neupro Patch (chemical name: rotigotine) for both the treatment of Parkinson's disease and Restless Legs Syndrome in Japan. Neupro Patch is the only ...
UCB will need to resolve issues concerning crystal formation before regulators in the USA approve the Belgian firm’s Neupro patch for Parkinson’s disease and restless legs syndrome. UCB will need to ...